Drug Type Small molecule drug |
Synonyms- |
Target |
Action inhibitors |
Mechanism PIP4K2A inhibitors(phosphatidylinositol-5-phosphate 4-kinase type 2 alpha inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Autoimmune Diseases of the Nervous System | Preclinical | United Kingdom | 17 Apr 2023 |